Orbital Pseudotumor: Diagnosis and Management in A Secondary Hospital
Article Sidebar
-
Orbital Pseudotumor, Idiopathic Inflammatory Syndrome, Corticosteroid therapy
Abstract
Objective: To increase the awareness in diagnosing orbital pseudotumor and its management, especially in a peripheral secondary hospital with limited facilities.
Case presentation: A 47 years old woman came with left eye (LE) protrusion, blurred vision, retrobulbar pain, and severe headache at regular intervals. This condition begun 8 months ago, and was diagnosed with orbital cellulitis, however the symptoms persisted until now. Physical examination of the LE showed a decreased in visual acuity, protrusion, chemosis and conjunctiva injection, increased in IOP, limited ocular motility, ipsilateral afferent pupillary defect and optic disc oedema. Plain and contrast CT-Scan showed a hypertrophy of ocular muscles with soft tissue swelling. Patient then diagnosed with idiopathic orbital inflammation and immediately prescribed with high dose steroid for 5 days with observation with glucose level observation for toxicity. Afterwards, she was given an oral corticosteroid and was tapered off for the next few weeks. At two months follow up, there were improvement in protrusion, motility and visual acuity.
Conclusion: A complete history taking, physical examination and appropriate additional examination are needed. In hospital or clinical setting with limited facilities, a thorough and comprehensive examination are needed in order to establish the diagnosis and management of orbital pseudotumor.
Full text article
References
Arthur S Grove Jr ALW. Orbital Pseudotumor Historical Origin and Modern Relevance. Ophthalmic Plast Reconstr Surg. 2013;29(5):341–6.
Apple D, Boniuk M, Mombaerts I. What is Pseudotumor Ob. 1996;41(I).
Shields JA, Shields CL, Scartozzi R. Survey of 1264 Patients with Orbital Tumors and Simulating Lesions The 2002 Montgomery Lecture , Part 1. 2004;997–1008.
Swamy BN. Idiopathic orbital inflammatory syndrome : Clinical features and treatment outcomes. 2007;1667–71.
Chirapapaisan N, Chuenkongkaew W, Pornpanich K, V angveeravong S. Orbital Pseudotumor : Clinical Features and Outcomes. 2007;215–8.
Smitt MC, Donaldson SS. Radiation Therapy 1. Arthur S Grove Jr ALW. Orbital Pseudotumor Historical Origin and Modern Relevance. Ophthalmic Plast Reconstr Surg. 2013;29(5):341–6.
Apple D, Boniuk M, Mombaerts I. What is Pseudotumor Ob. 1996;41(I).
Shields JA, Shields CL, Scartozzi R. Survey of 1264 Patients with Orbital Tumors and Simulating Lesions The 2002 Montgomery Lecture , Part 1. 2004;997–1008.
Swamy BN. Idiopathic orbital inflammatory syndrome?: Clinical features and treatment outcomes. 2007;1667–71.
Chirapapaisan N, Chuenkongkaew W, Pornpanich K, Vangveeravong S. Orbital Pseudotumor?: Clinical Features and Outcomes. 2007;215–8.
Smitt MC, Donaldson SS. Radiation Therapy for Benign Disease of the Orbit. 1999;9(2):179–89.
Yuen SJA, Rubin PAD. Idiopathic orbital inf lammation?: ocular mechanisms and clinicopathology. 2002;15:121–6.
Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. 2002;347–51.
Espinoza GM. Orbital Inflammatory Pseudotumors?: Etiology , Differential Diagnosis , and Management. 2010;443–7.
Evaluation R, Weber AL, Romo LV, Sabates NR. PSEUDOTUMOR OF THE ORBIT. 1999;37(1).
Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS. Infliximab Therapy for the Treatment of Refractory Ocular Inflammatory Disease. 2015;125(7):895–900.
Spindle J, Tang SX, Davies B, Wladis EJ, Piozzi E, Pellegrini M, et al. Pediatric Idiopathic Orbital Inflammation?: Clinical Features of 30 Cases. 2016;32(4):270–4.
Eshraghi B, Ali S, Abtahi M. Clinical characteristics , histopathology , and treatment outcomes in adult and pediatric patients with nonspecific orbital inflammation. J Curr Ophthalmol [Internet]. 2019;31(3):327–34. Available from: https://doi.org/10.1016/j.joco.2019.03.004
Mendenhall WM, Lessner AM. Orbital Pseudotumor TREATMENT. 2010;33(3):304–6.
Ghavami Y, Yau AY, Ziai K, Maducdoc MM, Djalilian HR. Inflammatory pseudotumour of the temporomandibular joint. 2015;1999:287–9.
Sharma P, Kaur J, Kumar R, Thami GP. Idiopathic orbital inflammatory syndrome?: a dermatological perspective. 2020;59–61.
Harris GJ. Idiopathic Orbital Inflammation?: A Pathogenetic Construct and Treatment Strategy. 2006;22(2):79–86.
Chaudhry N, Srivastava A, Joshi L. Journal of the Neurological Sciences Hemifacial spasm?: The past , present and future. J Neurol Sci [Internet]. 2015; Available from: http://dx.doi.org/10.1016/j.jns.2015.06.032
Robert C. Radiotherapy for Idiopathic Inflammatory Orbital Pseudotumor. Arch Ophthalmol. 1981;99.
Atlas S, Savino PJ, Bosley TM, Rubenstein J. The Results of Radiotherapy for Orbital Pseudotumor. Int J Radiat Oncol. 1989;(July):407–11.
Orcutt JC, Garner A, Henk JM, Wright JE. Treatment of idiopathic inflammatory orbital pseudotumours by radiotherapy. 1983;570–4.
Zacharopoulos IP, Papadaki T, Manor RS, Briscoe D. Treatment of Idiopathic Orbital Inflammatory Disease with Cyclosporine-A?: A Case Presentation. 2009;24(6):260–1.
Bielory L, Frohman LP. Low-dose Cyclosporine Therapy of Granulomatous Optic Neuropathy and Orbitopathy. Ophthalmology [Internet]. 1987;98(11):1732–6. Available from: http://dx.doi.org/10.1016/S0161-6420(91)32064-5
Larget-piet B. Vacuum sign in spondylodisci- tis due to H aphrophilus Idiopathic orbital myositis?: treatment with cyclosporin Non-Hodgkin ’ s lymphoma?: initial manifestation. 1987;84–6.
Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. 2001;1220–4.
Anderson J, Thomas T. C ASE R EPORT • O BSERVATIONS DE CAS Orbital pseudotumour presenting as orbital cellulitis ABSTRACT. 2017;8(2):123–5.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.